Ro Raises $500M in Series D
Ro has successfully raised $500M in a Series D at a $5B valuation led by General Catalyst, TCV.
Company Overview
Ro is a HealthTech company headquartered in New York, NY, founded in 2017 with 800+ employees.
Direct-to-patient healthcare platform
Fundraising Details
- Amount Raised: $500M
- Round Type: Series D
- Valuation: $5B
- Date: 2021-03-18
- Investors: General Catalyst, TCV
About Ro
Direct-to-patient healthcare platform The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: New York, NY
- Founded: 2017
- Team Size: 800+
- Industry: HealthTech
What This Means
This funding round demonstrates strong investor confidence in Ro's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Ro's successful fundraising reflects the strong fundamentals and growth potential in this space.
Valuation Milestone
Reaching a $5B valuation marks an important milestone for Ro, positioning the company among notable players in the HealthTech industry.
Looking Ahead
With this new capital, Ro is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
---
This fundraising news was reported on 2021-03-18. For more information about Ro, visit their headquarters at New York, NY.
